U.S. Markets closed

  • S&P 500

    4,471.37
    +33.11 (+0.75%)
     

  • Dow 30

    35,294.76
    +382.20 (+1.09%)
     

  • Nasdaq

    14,897.34
    +73.91 (+0.50%)
     

  • Russell 2000

    2,265.65
    -8.52 (-0.37%)
     

  • Gold

    1,768.10
    -29.80 (-1.66%)
     

  • EUR/USD

    1.1606
    +0.0005 (+0.0464%)
     

  • 10-Yr Bond

    1.5760
    +0.0570 (+3.75%)
     

  • Vix

    16.30
    -0.56 (-3.32%)
     

  • GBP/USD

    1.3751
    +0.0074 (+0.5418%)
     

  • USD/JPY

    114.2000
    +0.5230 (+0.4601%)
     

  • BTC-USD

    59,363.99
    -1,259.83 (-2.08%)
     

  • CMC Crypto 200

    1,464.06
    +57.32 (+4.07%)
     

  • FTSE 100

    7,234.03
    +26.32 (+0.37%)
     

  • Nikkei 225

    29,068.63
    +517.70 (+1.81%)
     

Yahoo Finance Live: Midday Movers - Jan 30th, 2018

Yahoo Finance's LIVE stock market coverage and analysis.

Recommended Stories

  • Suze Orman: Make these 5 moves to stay out of the poorhouse in retirement

    When it comes down to it, the greatest threat to your comfort in retirement is you.

  • In a world of paltry 0.06% interest rates, these income stocks yield up to 10.2%

    Low-interest rates still got you down? Try this trio of dividend stocks on for size.

  • Elon Musk Has Disrupted the Auto and Space Industries. 1 More Thing He Can Add to His Resume.

    Elon Musk has built two industrial behemoths—Tesla and SpaceX—revolutionizing two industries. But that isn't all he has done to change industry.

  • 3 Unstoppable Stocks You Can Buy Right Now for Less Than $100

    Despite their stock prices taking a breather, these companies' operations seem to be unstoppable.

  • My girlfriend says I should tip in restaurants. I say waitstaff are just like construction and fast-food workers. Who’s right?

    ‘As long as all service staff are doing their job and getting paid an hourly wage, there is no reason to tip anyone.’

  • 10 Extreme Dividend Stocks With Upside Potential

    In this article, we discuss the 10 extreme dividend stocks with upside potential. If you want to skip our detailed analysis of these stocks, go directly to the 5 Extreme Dividend Stocks With Upside Potential. Growth stocks have exploded in value at the marketplace over the past few months due in part to the influx […]

  • This Chinese Tech Giant Just Got a Big-Time Fine, So Why Is Its Stock Skyrocketing?

    Chinese stocks have sold off en masse since the Spring, but is now the time for aggressive investors to go bargain-hunting in the Middle Kingdom? One indication could be the recent case of Meituan (OTC: MPNGF), the largest food delivery company in China, with businesses in daily deals, hotel bookings, community e-commerce, restaurant software, and grocery and drugstore delivery. On Oct. 8, China's State Administration for Market Regulation imposed a $534 million fine on Meituan -- a penalty for abusing its dominant market share in food delivery to force restaurants into exclusivity arrangements.

  • He Wants to Retire in 15 Years, When He Turns 65. A Financial Adviser Weighs In.

    The couple, who live in Lake Ozark, Mo., also receive $500 a month in child-care credits from the recent stimulus package. Together, their two traditional IRAs contain $285,000. In addition, Mr. Lynch has a small pension that will pay $325 a month when he turns 59½.

  • Want $5,000 in Annual Dividend Income? Invest $57,000 in These Ultra-High-Yield Stocks

    With yields ranging from 7.7% to 10.4%, these dividend stocks can help maximize income-investors' returns.

  • Bearish Bets: 2 Stocks You Really Should Consider Shorting This Week

    Using technical analysis of the charts of those stocks, and, when appropriate, recent actions and grades from TheStreet's Quant Ratings, we zero in on five names. While we will not be weighing in with fundamental analysis, we hope this piece will give investors interested in stocks on the way down a good starting point to do further homework on the names. Nu Skin Enterprises Inc. recently was downgraded to Hold with a C+ rating by TheStreet's Quant Ratings.

  • When to Take Social Security: The Complete Guide

    How to decide whether to start collecting your retirement benefits at age 62, at your full retirement age (FRA), or even later.

  • 3 No-Brainer Biotech Stocks to Buy Right Now

    Here's why they selected Regeneron Pharmaceuticals (NASDAQ: REGN), Vertex Pharmaceuticals (NASDAQ: VRTX), and Viatris (NASDAQ: VTRS). Prosper Junior Bakiny (Regeneron Pharmaceuticals): Shares of Regeneron dropped like a rock amid September's broad market declines.

  • Got $1,000? Here Are 3 EVs That Are Good Long-Term Bets

    Investors interested in electric vehicles have more choices today than ever before. Here are three good ones.

  • 'Big Short' investor Burry says he's no longer betting against Tesla - CNBC

    Burry's Scion Asset Management said in a regulatory filing in mid-May it had put options on 800,100 Tesla shares as of the end of the first quarter. Based on Tesla's closing price of $667.93 at the end of the first quarter, the value of that many shares would have been about $534 million. "No, it was a trade," Burry was quoted as saying in an email to CNBC on Friday, when asked whether he was still shorting Tesla.

  • What to Watch for in GE's Earnings

    General Electric's (NYSE: GE) upcoming earnings report is unlikely to produce any significant surprises on a headline basis. After all, management tends to give wide guidance ranges, and CEO Larry Culp spoke extensively about trading conditions at a conference in mid-September. Investors will be very interested in putting the pieces together to build a picture for 2022 and beyond.

  • Jasper Therapeutics Stock Is up 127% in Three Days. How Much Higher Can It Go?

    There’s a new biotech in town flying under the Street’s radar. Jasper Therapeutics (JSPR) only went public in September via the SPAC route, and the stock still has a low profile on Wall Street. One analyst, however, has been taking notes, and he is decidedly positive. “We view JSPR as an emerging leader in the development of novel targeted conditioning agents for hematopoietic stem cell transplantation (HSCT) with lead candidate JSP191 and proprietary engineered hematopoietic stem cell (eHSC) pl

  • AT&T and Verizon set to deliver earnings as wireless competition builds

    Even with minimal impact from the latest iPhone launch, the growing competitiveness of the wireless industry will be on full display when telecommunications companies start reporting quarterly results in the week ahead.

  • 2 Innovative Semiconductor Stocks Set to Crush the Market in 2022

    Semiconductor returns might not be as solid in 2022 as they've been so far in 2021, so investors should stick to high-quality opportunities.

  • 2 Beaten-Down Growth Stocks Set to Shine in 2022

    The stock market has been strong in 2021, but not for all companies. However, a select few are set up for big things next year.

  • 3 Best Dividend Stocks for Retirement

    Admittedly, the average cash yield for dividend stocks in the S&P 500 is only 1.3%, and companies can theoretically end payouts anytime. Such conditions may not appeal to income investors when advisors like Charles Schwab believe retirees should save enough to withdraw 4% of their account value per year in retirement. Three examples which fit that bill are AbbVie (NYSE: ABBV), STORE Capital (NYSE: STOR), and Verizon Communications (NYSE: VZ) -- and they also pay rising dividends that even exceed Schwab's 4% recommended return.